BFRI · Biofrontera

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

660 Main Street, Woburn, MA, 01801, United States
Drug Manufacturers - Specialty & Generic
Healthcare

Market Cap

13.74M

52 Wk Range

$0.56 - $1.66

Previous Close

$0.93

Open

$0.93

Volume

318,852

Day Range

$0.87 - $0.94

Enterprise Value

20.21M

Cash

4.667M

Avg Qtr Burn

-1.658M

Insider Ownership

11.99%

Institutional Own.

20.72%

Qtr Updated

Jun 30th 2026